🔎 Trials Near Me

Beranda › Sarkoma Jaringan Lunak › New York › New York City

Uji klinis Sarkoma Jaringan Lunak di New York City, NY

19 studi untuk Sarkoma Jaringan Lunak mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06942442

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Study of CRD3874-SI in People With Solid Tumors

Menerima pesertaFase 1
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06021626

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

Menerima pesertaFase 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06797999

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Menerima pesertaFase 1/2
  • New York University Langone Health, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05732831

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Menerima pesertaFase 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT04577014

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Menerima pesertaFase 1
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Usia 12 hingga 85 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT03715933

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06644755

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Menerima peserta
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05837767

Actinium Therapy for Late-stage Aggressive Sarcomas

Menerima pesertaFase 1
  • Memorial Sloane Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07156565

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

Menerima pesertaStudi observasional
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Semua usia · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT00579566

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07089992

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Menerima pesertaFase 1
  • Zai Lab Site 02002, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT07374848

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

Menerima peserta
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT06129903

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT04332874

A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Centre, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT05755113

Phase II Trial of Lung Chemoemobolization

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mar 2026 · NCT05672108

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Menerima pesertaFase 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Usia 2 hingga 30 · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT05734066

Uji klinis Sarkoma Jaringan Lunak di kota lain

Studi lain di New York City

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.